Published in J Med Chem on February 10, 2005
Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues. J Med Chem (2008) 1.34
The design, synthesis, and evaluation of organ-specific iron chelators. J Med Chem (2006) 1.14
(S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity. J Med Chem (2006) 0.93
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution. J Med Chem (2007) 0.86
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity. Biometals (2010) 0.84
Desferrithiocin: a search for clinically effective iron chelators. J Med Chem (2014) 0.76
Metabolically programmed iron chelators. Bioorg Med Chem (2015) 0.75
Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood (2010) 3.03
Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr (2003) 2.95
Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med (2002) 2.23
Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood (2011) 1.92
High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg (2008) 1.72
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg (2003) 1.54
Diffuse descending necrotizing mediastinitis: surgical therapy and outcome in a single-centre series. Eur J Cardiothorac Surg (2012) 1.45
An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A (2002) 1.43
Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy. J Lab Clin Med (2003) 1.35
Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues. J Med Chem (2008) 1.34
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood (2010) 1.17
Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver. Magn Reson Med (2009) 1.15
The design, synthesis, and evaluation of organ-specific iron chelators. J Med Chem (2006) 1.14
Myocardial T2 quantitation in patients with iron overload at 3 Tesla. J Magn Reson Imaging (2009) 1.10
Transfusion of stored blood impairs host defenses against Gram-negative pathogens in mice. Transfusion (2014) 1.09
Analysis with respect to instrumental variables for the exploration of microarray data structures. BMC Bioinformatics (2006) 1.08
Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. Br J Haematol (2009) 1.07
Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health (2007) 1.06
Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest (2016) 0.97
Cerebral malaria: a new way forward with magnetic resonance imaging (MRI). Am J Trop Med Hyg (2009) 0.97
Impact of laughter on air trapping in severe chronic obstructive lung disease. Int J Chron Obstruct Pulmon Dis (2008) 0.95
Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy. J Lab Clin Med (2003) 0.95
Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency. J Med Chem (2003) 0.94
Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn Reson Med (2010) 0.94
(S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity. J Med Chem (2006) 0.93
Iron deficiency in whole blood donors. Transfusion (2011) 0.92
Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy. J Lab Clin Med (2003) 0.90
Methods for noninvasive measurement of tissue iron in Cooley's anemia. Ann N Y Acad Sci (2005) 0.90
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health (2008) 0.90
Vibriobactin antibodies: a vaccine strategy. J Med Chem (2009) 0.89
Risk assessment in the first fifteen minutes: a prospective cohort study of a simple physiological scoring system in the emergency department. Crit Care (2011) 0.88
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand. Southeast Asian J Trop Med Public Health (2003) 0.87
Polyamine-vectored iron chelators: the role of charge. J Med Chem (2005) 0.87
A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Diabetes Metab Res Rev (2014) 0.87
Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology (2006) 0.87
Hyponatraemia and hypokalaemia in adults with uncomplicated malaria in Thailand. Trop Doct (2008) 0.86
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution. J Med Chem (2007) 0.86
Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron. Ann N Y Acad Sci (2010) 0.86
Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier. Chirality (2003) 0.86
Deferiprone and hepatic fibrosis. Blood (2003) 0.85
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity. Biometals (2010) 0.84
Clustering analysis of Salmonella enterica serovar Typhi isolates in Korea by PFGE, ribotying, and phage typing. Foodborne Pathog Dis (2009) 0.83
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand. Korean J Parasitol (2006) 0.82
The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues. J Med Chem (2010) 0.82
Hemodynamic assessment of critically ill patients using a miniaturized transesophageal echocardiography probe. Crit Care (2013) 0.82
Six-minute walk test enhanced by mobile telemetric cardiopulmonary monitoring. Respiration (2010) 0.82
Enhanced protection of Ins-1 beta cells from apoptosis under hypoxia by delivery of DNA encoding secretion signal peptide-linked exendin-4. J Drug Target (2009) 0.82
Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease. BMC Pulm Med (2014) 0.81
Effect of hormone replacement therapy on cognitive function in women with chronic schizophrenia. Int J Psychiatry Clin Pract (2006) 0.81
Complete genome sequence of Salmonella bacteriophage SS3e. J Virol (2012) 0.81
Does a negative D-dimer test rule out aortic dissection? Swiss Med Wkly (2007) 0.81
Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate. NMR Biomed (2010) 0.81
Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Neuropsychobiology (2008) 0.80
Plasma hepcidin of Ethiopian highlanders with steady-state hypoxia. Blood (2013) 0.80
Measurement of arsenic bioavailability in soil using a primate model. Toxicol Sci (2002) 0.80
Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia. J Magn Reson Imaging (2011) 0.79
Polyamine-iron chelator conjugate. J Med Chem (2003) 0.79
Left ventricular torsion abnormalities in septic shock and corrective effect of volume loading: a pilot study. Can J Cardiol (2013) 0.79
Desferrithiocin analogue based hexacoordinate iron(III) chelators. J Med Chem (2003) 0.78
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning. Blood (2002) 0.78
Deletion of lipoprotein PG0717 in Porphyromonas gingivalis W83 reduces gingipain activity and alters trafficking in and response by host cells. PLoS One (2013) 0.78
Structure-activity relationships among desazadesferrithiocin analogues. Adv Exp Med Biol (2002) 0.77
MR characterization of hepatic storage iron in transfusional iron overload. J Magn Reson Imaging (2013) 0.77
Desferrithiocin analogues and nephrotoxicity. J Med Chem (2008) 0.77
Dual-wavelength excitation for fluorescence-based quantification of zinc protoporphyrin IX and protoporphyrin IX in whole blood. J Biophotonics (2013) 0.77
Desferrithiocin: a search for clinically effective iron chelators. J Med Chem (2014) 0.76
Management of the thalassemias. Cold Spring Harb Perspect Med (2013) 0.76
Measurement and correction of stimulated echo contamination in T2-based iron quantification. Magn Reson Imaging (2012) 0.76
Measurements of mRNA degradation in Borrelia burgdorferi. J Bacteriol (2013) 0.76
Desferrithiocin analogue uranium decorporation agents. Int J Radiat Biol (2009) 0.75
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles. J Med Chem (2012) 0.75
Cercaria caribbea LVIII Cable, 1963 (Digenea: Cyathocotylidae) in the Republic of Korea and its surface ultrastructure. Korean J Parasitol (2012) 0.75
Safety of short-term valacyclovir as an anti-sickling agent in sickle-cell anemia. Pediatr Blood Cancer (2011) 0.75
Synthesis and biological evaluation of aminopolyamines. J Med Chem (2005) 0.75
Main pulmonary artery stenosis caused by fibrocalcified mass in a young infant. J Korean Med Sci (2002) 0.75
Bandwidth-variable tunable optical filter unit for illumination and spectral imaging systems using thin-film optical band-pass filters. Rev Sci Instrum (2013) 0.75
Comparison of iron chelator efficacy in iron-overloaded beagle dogs and monkeys (Cebus apella). Comp Med (2004) 0.75